| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |